Is It Too Late To Consider Madrigal Pharmaceuticals (MDGL) After Recent Share Price Surge?
- Investors may be wondering if Madrigal Pharmaceuticals at around US$519.75 a share is still offering value, or if the easy gains are already behind it.
- The stock has been volatile recently, with a 1.9% decline over the last week, a 20.0% return over 30 days, a 12.5% decline year to date, and a 65.6% return over the past year, alongside very large gains over 5 years.
- Recent headlines around Madrigal have focused on its position in the biotech space and the market’s shifting expectations for its drug pipeline and regulatory progress. That changing backdrop helps explain why the share price has moved so sharply over different time frames.
- On Simply Wall St’s valuation checklist, Madrigal earns a 4 out of 6 value score. The next sections…
Source link
